Combination of vinorelbine, epirubicin, and cyclophosphamide as neoadjuvant chemotherapy for locally advanced breast cancer: Phase II study

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 25, Issue 3, 2002, Pages 303-307

  Braud, A C ^a   Levy, E ^a   Feuilhade, F ^a   Otmezguine, Y ^a   Calitchi, E ^a   Kirova, Y ^a   Le Bourgeois, J P ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

Epirubicin; Locally advanced breast cancer; Neoadjuvant chemotherapy; Phase II study; Vinorelbine

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; NAVELBINE;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; EPIRUBICIN; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; SURVIVAL ANALYSIS; VINBLASTINE;

EID: 0036269679     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200206000-00021     Document Type: Article

References (16)

1. Effect of preoperative therapy for primary breast cancer on local-regional disease, disease-free survival and survival results from NSABP B-18
2. First-line chemotherapy in operable breast neoplasms: Results of 3 protocols
3. Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer
4. Neoadjuvant chemotherapy or chemotherapy and endocrine therapy in locally advanced breast carcinoma
5. Effect of preoperative chemotherapy on the outcome of patients with operable breast cancer
6. Primary chemotherapy in breast cancer. Correlation between tumor response and patient outcome
7. Vinorelbine in the treatment of breast cancer: Current status and prospective for the future
8. Conceptual basis for advances in the systemic drug therapy of breast cancer
9. Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast
10. Long term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline based neoadjuvant chemotherapy
11. A phase II trial of neoadjuvant methotrexate vinblastine doxorubicin and cisplatin in the treatment of patients with locally advanced breast carcinoma
12. Primary chemotherapy in operable breast cancer: Eight-year experience at the Milan Cancer Institute
13. Primary chemotherapy in the treatment of breast cancer. Significantly enhanced clinical and pathological response with docetaxel
14. High pathological response rate induced by primary docetaxel monotherapy in operable breast cancer
15. Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin and cyclophosphamide as neoadjuvant therapy in patients operable breast cancer